Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Burstein Jennifer Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 4 Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 19,441 options to buy @ $12.46, valued at $242.2k
06/08/2022 4 Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 21,000 options to buy @ $12.96, valued at $272.2k
06/25/2021 4 Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 11,650 options to buy @ $40.37, valued at $470.3k
06/05/2020 4 Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 14,777 options to buy @ $26.53, valued at $392k
09/12/2019 4 Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 29,555 options to buy @ $28.8, valued at $851.2k
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/02/2019 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 20,000 options to buy @ $139.77, valued at $2.8M
12/12/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 100 shares @ $130.79, valued at $13.1k
Sold 400 shares @ $132.44, valued at $53k
Sold 100 shares @ $133.34, valued at $13.3k
Sold 550 shares @ $134.71, valued at $74.1k
Sold 100 shares @ $136.04, valued at $13.6k
Sold 200 shares @ $135.69, valued at $27.1k
Sold 587 shares @ $136.98, valued at $80.4k
Sold 263 shares @ $137.88, valued at $36.3k
Sold 100 shares @ $139.36, valued at $13.9k
Sold 100 shares @ $140.48, valued at $14k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
11/28/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 500 shares @ $151.57, valued at $75.8k
Sold 250 shares @ $152.39, valued at $38.1k
Sold 100 shares @ $153.3, valued at $15.3k
Sold 300 shares @ $155.13, valued at $46.5k
Sold 100 shares @ $156.04, valued at $15.6k
Sold 200 shares @ $137.89, valued at $27.6k
Sold 350 shares @ $138.95, valued at $48.6k
Sold 200 shares @ $140.94, valued at $28.2k
Sold 200 shares @ $143.84, valued at $28.8k
Sold 100 shares @ $147.09, valued at $14.7k
Sold 100 shares @ $148.2, valued at $14.8k
10/05/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 550 shares @ $166.1391, valued at $91.4k
Sold 200 shares @ $167.25, valued at $33.5k
Sold 200 shares @ $168.785, valued at $33.8k
Sold 300 shares @ $170.95, valued at $51.3k
Sold 750 shares @ $165.5267, valued at $124.1k
Sold 500 shares @ $166.756, valued at $83.4k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
08/15/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 800 shares @ $158.0025, valued at $126.4k
Sold 440 shares @ $158.6882, valued at $69.8k
Sold 10 shares @ $160.17, valued at $1.6k
Sold 450 shares @ $159.4656, valued at $71.8k
Sold 800 shares @ $160.6488, valued at $128.5k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
Exercised 1,250 options to buy @ $11.35, valued at $14.2k
07/11/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 200 shares @ $184.72, valued at $36.9k
Sold 500 shares @ $186.666, valued at $93.3k
Sold 600 shares @ $187.5283, valued at $112.5k
Sold 100 shares @ $189.12, valued at $18.9k
Sold 100 shares @ $191.64, valued at $19.2k
Exercised 1,500 options to buy @ $11.35, valued at $17k
06/21/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 800 shares @ $176.2898, valued at $141k
Sold 500 shares @ $177.15, valued at $88.6k
Sold 400 shares @ $178.2025, valued at $71.3k
Exercised 1,700 options to buy @ $11.35, valued at $19.3k
05/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 300 shares @ $129.4551, valued at $38.8k
Sold 300 shares @ $130.77, valued at $39.2k
Sold 800 shares @ $132.0625, valued at $105.7k
Sold 300 shares @ $133.6233, valued at $40.1k
Exercised 1,700 options to buy @ $11.35, valued at $19.3k
03/15/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 100 shares @ $128.85, valued at $12.9k
Sold 700 shares @ $130.2286, valued at $91.2k
Sold 500 shares @ $131.754, valued at $65.9k
Sold 300 shares @ $133.04, valued at $39.9k
Sold 100 shares @ $134.28, valued at $13.4k
Exercised 1,700 options to buy @ $11.35, valued at $19.3k
02/14/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 300 shares @ $91.6133, valued at $27.5k
Sold 600 shares @ $92.865, valued at $55.7k
Sold 700 shares @ $94.0401, valued at $65.8k
Sold 100 shares @ $94.73, valued at $9.5k
Exercised 1,700 options to buy @ $11.35, valued at $19.3k
01/18/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,500 shares @ $87.4952, valued at $131.2k
Exercised 1,500 options to buy @ $11.35, valued at $17k
01/05/2018 4 Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 40,000 options to buy @ $84.88, valued at $3.4M
12/18/2017 4 Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 900 shares @ $82.6646, valued at $74.4k
Sold 800 shares @ $83.9447, valued at $67.2k
Exercised 1,700 options to buy @ $11.35, valued at $19.3k
11/29/2017 4 Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,100 shares @ $74.19, valued at $81.6k
Sold 300 shares @ $75.1833, valued at $22.6k
Sold 300 shares @ $76.7633, valued at $23k
Exercised 1,700 options to buy @ $11.35, valued at $19.3k
11/01/2017 4 Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,300 shares @ $86.8877, valued at $113k
Sold 200 shares @ $87.7735, valued at $17.6k
Sold 200 shares @ $88.55, valued at $17.7k
Exercised 1,700 options to buy @ $11.35, valued at $19.3k
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2017 4 Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 12,000 options to buy @ $43.56, valued at $522.7k
12/08/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy